Dr. Brawer on the Significance of the Prolaris Genetic Test for Prostate

Michael Brawer, MD
Published: Wednesday, Aug 16, 2017



Michael Brawer, MD, vice president of medical affairs, Myriad Genetic Laboratories, discusses the significance of the Prolaris genetic test in predicting prostate cancer aggressiveness in African-American men.

This was significant because we are moving more towards the utilization of active surveillance in the United States, explains Brawer. With the statistics involving African Americans, it is important to know whether tests are reliable. With respect to Prolaris, it was necessary to determine if the test worked for all patient populations, states Brawer.

SELECTED
LANGUAGE


Michael Brawer, MD, vice president of medical affairs, Myriad Genetic Laboratories, discusses the significance of the Prolaris genetic test in predicting prostate cancer aggressiveness in African-American men.

This was significant because we are moving more towards the utilization of active surveillance in the United States, explains Brawer. With the statistics involving African Americans, it is important to know whether tests are reliable. With respect to Prolaris, it was necessary to determine if the test worked for all patient populations, states Brawer.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Oncology Briefings™: Current Perspectives on Preventing and Managing Tumor Lysis SyndromeJun 30, 20191.0
Publication Bottom Border
Border Publication
x